扩大MYCN对IV期神经母细胞瘤患者的瘤反应和复发的影响
Yvette A H Matser1, André B P van Kuilenburg2,3, Atia Samim1,4
1Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
JCO precision oncology
|March 12, 2026
概括
在高风险神经母细胞瘤患者中,MYCN放大导致更快的缓解,但复发风险更高. 这一发现强调了MYCN放大作为影响神经母细胞瘤疾病进展和复发的关键因素.
科学领域:
- 儿科瘤学 儿科瘤学
- 癌症基因组学 癌症基因组学
- 分子诊断学 分子诊断学
背景情况:
- MYCN放大 (MYCN-A) 是神经母细胞瘤的一个关键预后指标.
- 在转移性高风险神经母细胞瘤中,MYCN-A对疾病进展的影响需要进一步研究.
研究的目的:
- 为了分析IV期神经母细胞瘤患者的反应和复发模式,有或没有MYCN放大.
- 评估MYCN放大作为这个患者队列的预后标记.
主要方法:
- 通过光在现场杂交,整个外基因组测序或SNP分析评估的MYCN放大.
- 使用国际神经母细胞瘤应答标准确定完全缓解和生存结果.
- 与MYCN状态和SIOPEN在MIBG光学上的分数相关的复发模式分析.
主要成果:
- 在164名高风险神经母细胞瘤患者中,MYCN放大被观察到30%的患者.
- MYCN-A显著影响了整体存活率,并与更快的完全缓解有关.
- 患有MYCN-A的患者在MIBG扫描上显示出更高的复发概率和较低的SIOPEN得分.
结论:
- 尽管缓解迅速,但MYCN放大与转移性高风险神经母细胞瘤复发风险增加有关.
- MYCN放大,特别是当被SIOPEN分数分层时,是复发的重要预测因素.
相关概念视频
Abnormal Proliferation
5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Induced Pluripotent Stem Cells
5.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
5.9K


